Clinical Evidence · HAIR BENEFITS
Hair visibly restored
68.9%
REDUCTION IN HAIR LOSS(WITHOUT BULB COUNT)
Hair Loss
In a 75-day randomised, double-blind, placebo-controlled trial, hair loss reduced by 68.9% versus placebo. The follicle, no longer suppressed by elevated cortisol, recovers. Telogen percentage falls. Hair density improves not because a growth serum was applied, but because the follicle is doing what it was designed to do when the mechanism is addressed.
Hair Density
In a 75-day randomised, double-blind, placebo-controlled study, hair density improved by 4.64%, reflecting a stronger and more active follicular environment. The follicle, no longer impacted by stress-mediated disruption, supports fuller, denser hair, not by external stimulation, but by restoring its natural growth function.
Hair Growth
Hair growth improved by 7.28%, supported by a measurable shift toward the anagen phase and reduced telogen percentage. Growth increases not because a stimulant was applied, but because the hair cycle is functioning as it was designed to when the underlying mechanism is addressed.
Scalp Nutrition
Cortisol constricts dermal vasculature, reducing blood flow to the follicle. As cortisol normalizes, scalp circulation recovers, improving the follicle’s nutritional environment. The follicle, no longer impacted by elevated cortisol, is better supported at the root, promoting stronger, more resilient hair through restored function, not external stimulation.
75-DAY DB-RCT · PUBLISHED
The follicle recovers. The published data confirms it.
0%
Reduction in hair loss (with bulb count)
0%
Reduction in telogen percentage
0%
Improvement in hair growth
0%
Improvement in hair density